Pharmaids Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | BSE: 524572
₹69.99 -0.26 (-0.37 %)
Last Updated: 13 Mar 2025 12:00 AM
Overview
Open (₹) 71.66
High (₹) 71.66
Low (₹) 67.00
Prev. Close (₹) 70.25
Volume 10,439
VWAP (₹) 68.24
ROCE (%) -17.61
Industry P/E 43.95
TTM P/E -20.00
P/B Ratio 3.50
Market Cap (₹) Cr.246.84
Dividend Yield (%)--
EPS (₹) -3.56
ROE-17.81%
Sales Growth (%) --
Profit Growth (%)56.74
Day Range
71.6671.66
52 Week Range
31.9087.46
Historical Returns
Returns (6M)
66.76 %
Returns (1Y)
31.39 %
Returns (3Y)
412.75 %
Returns (5Y)
1316.8 %
Returns (6M)
66.76 %
Returns (1Y)
31.39 %
Returns (3Y)
412.75 %
Returns (5Y)
1316.8 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Increasing Revenue every Quarter for the past 4 Quarters
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Positive ROC (9) indicates upward momentum.
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
RSI 48.53
MFI 25.68
ATR 5.06
Commodity Channel Index 8.24
ROC125 56.49
ROC21 0.59
Williams %R -41.05
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 71.61 | 74.49 | 76.99 | 69.11 | 66.23 | 63.73 | 60.85 |
Week Ago | 67.13 | 67.13 | 67.13 | 67.13 | 67.13 | 67.13 | 67.13 |
Month Ago | 71.70 | 72.30 | 73.05 | 70.95 | 70.35 | 69.60 | 69.00 |
EMA & SMA
69.99
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 68.88
9 Day 65.24
10 Day 65.59
12 Day 66.59
14 Day 67.37
20 Day 68.49
26 Day 69.08
50 Day 69.47
100 Day 62.55
200 Day 55.04
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
TOPGAIN FINANCE PRIVATE LIMITED | bulk | Buy | 19 Dec, 2022 | ₹32.42 | 80,000 | BSE |
EPITOME TRADING AND INVESTMENTS | bulk | Buy | 19 Dec, 2022 | ₹32.45 | 75,000 | BSE |
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Sell | 15 Dec, 2022 | ₹29.28 | 94,011 | BSE |
TOPGAIN FINANCE PRIVATE LIMITED | bulk | Buy | 15 Dec, 2022 | ₹28.05 | 52,000 | BSE |
EPITOME TRADING AND INVESTMENTS | bulk | Buy | 15 Dec, 2022 | ₹29.33 | 60,456 | BSE |
BP EQUITIES PVT. LTD. | bulk | Sell | 14 Dec, 2022 | ₹29.49 | 57,806 | BSE |
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Buy | 14 Dec, 2022 | ₹28.93 | 94,011 | BSE |
EPITOME TRADING AND INVESTMENTS | bulk | Buy | 14 Dec, 2022 | ₹29.29 | 1,00,000 | BSE |
BP EQUITIES PVT. LTD. | bulk | Buy | 14 Dec, 2022 | ₹29.50 | 12 | BSE |
RAVI KUMAR KROVVIDI | bulk | Sell | 26 Jul, 2022 | ₹12.10 | 1,50,000 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
01 Jan, 2025 | MALIEMADOM RAMASWAMY IYER MAHADEVAN | Disposal | ₹61.49 | 20,978 | BSE |
31 Dec, 2024 | Shreedhara Shetty | Disposal | ₹63.94 | 1,28,071 | BSE |
26 Dec, 2024 | Shreedhara Shetty | Disposal | ₹60.90 | 76,800 | BSE |
23 Dec, 2024 | Dr. Shankarappa Nagaraja Vinaya Babu | Acquisition | ₹25.00 | 18,20,854 | BSE |
20 Dec, 2024 | Shreedhara Shetty | Disposal | ₹58.47 | 23,813 | BSE |
17 Dec, 2024 | Shreedhara Shetty | Disposal | ₹59.20 | 8,204 | BSE |
16 Dec, 2024 | Shreedhara Shetty | Disposal | ₹60.75 | 19,353 | BSE |
12 Dec, 2024 | Shreedhara Shetty | Disposal | ₹58.51 | 36,268 | BSE |
12 Dec, 2024 | Shreedhara Shetty | Disposal | ₹55.26 | 29,229 | BSE |
11 Dec, 2024 | Shreedhara Shetty | Disposal | ₹53.11 | 37,973 | BSE |
Corporate Actions
No corporate actions available.
Announcements
Date | Source | Detail |
---|---|---|
19 Feb, 2025 | BSE India | Postal Ballot notice dated February 12, 2025. |
13 Feb, 2025 | BSE India | Disclosure under regulation 30 of SEBI (LODR), regulation 2015 - Intimation on loan agreement. |
12 Feb, 2025 | BSE India | Intimation of alteration in capital clause of the Memorandum of Association of the Company, subject to approval of shareholders of the Company |
12 Feb, 2025 | BSE India | This is to inform you that Board of Directors in their meeting held today i.e. February 12, 2025 considered and approved the re-appointment of Mr.Venu Madhava Kaparthy (DIN: 00021699) as Whole Time Director designated as Executive Director of the Company and Ms.Mini Manikantan (DIN: 09663184) as Whole Time Director designated as Executive Director of the Company Subject to approval of the members of the Company. |
12 Feb, 2025 | BSE India | Integrated filing (financials) for the quarter and nine months ended December 31, 2024. |
12 Feb, 2025 | BSE India | Financial results for the Quarter and Nine Months ended December 31, 2024 |
12 Feb, 2025 | BSE India | Unaudited Financial Results For The Quarter And Nine Months Ended 31st December 2024 |
07 Feb, 2025 | BSE India | PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve the unaudited Financial results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2024. |
06 Feb, 2025 | BSE India | In terms of Regulation 30, this is to inform you that the Board of Directors of the Company has approved and passed resolution by circulation on February 06, 2025 for acquisition (Purchase) of Industrial Land Plots.\r\nDetails are attached. |
05 Feb, 2025 | BSE India | This is in furtherance to our previous intimations regarding investment and update on the same in Anugraha Chemicals (\Firm\). Details as required under SEBI Listing Regulations, 2015 disclosure circular has been attached. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 10 Feb, 2025 | 12 Feb, 2025 |
Quarterly Results | -- | 08 Nov, 2024 | 13 Nov, 2024 |
Audited Results | -- | 22 May, 2024 | 28 May, 2024 |
Quarterly Results | -- | 05 Feb, 2024 | 12 Feb, 2024 |
Preferential issue of shares | -- | 04 Jan, 2024 | 06 Jan, 2024 |
Quarterly Results | -- | 07 Nov, 2023 | 11 Nov, 2023 |
Quarterly Results | -- | 31 Jul, 2023 | 04 Aug, 2023 |
Audited Results | -- | 24 May, 2023 | 29 May, 2023 |
Quarterly Results | -- | 06 Feb, 2023 | 13 Feb, 2023 |
Others | -- | 13 Jan, 2023 | 17 Jan, 2023 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Apr, 2024 | Mar, 2024 | Dec, 2023 |
---|
About Pharmaids Pharmaceuticals
Pharmaids Pharmaceuticals is a Public Limited Listed company incorporated on 01/03/1989 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L52520KA1989PLC173979 and registration number is 173979. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 0.03 Cr. and Equity Capital is Rs. 35.27 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1989
Managing Director
-- --
NSE Symbol
--
Pharmaids Pharmaceuticals Management
Name | Designation |
---|---|
Dr. Shankarappa Nagaraja Vinaya Babu | Chairman, Non Ind & Non Exe Director |
Mr. Venu Madhava Kaparthy | Executive Director |
Ms. Mini Manikantan | Executive Director |
Mr. Shreedhara Shetty | Non Exe.Non Ind.Director |
Mr. Methuku Nagesh | Independent Director |
Mr. P N Vijay | Independent Director |
Mr. Mopperthy Sudheer | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45 ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45 ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Pharmaids Pharmaceuticals
What is the share price of Pharmaids Pharmaceuticals?
The share price of Pharmaids Pharmaceuticals on 13 Mar, 2025 is ₹ 69.99.
What is 52W high and 52W low share price of Pharmaids Pharmaceuticals?
The highest and lowest 52W share prices of Pharmaids Pharmaceuticals are ₹ 87.460 and ₹ 31.900
What is the market cap of Pharmaids Pharmaceuticals?
The market capitalization of Pharmaids Pharmaceuticals as of 13 Mar, 2025 is ₹ 246.84 Crores
What is the P/E ratio of Pharmaids Pharmaceuticals?
The current P/E ratio of Pharmaids Pharmaceuticals as of 13 Mar, 2025 is 43.95
What is the PB ratio of Pharmaids Pharmaceuticals?
The PB ratio of Pharmaids Pharmaceuticals as of 13 Mar, 2025 is 3.50
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)